Discovering New Therapies for Kidney Fibrosis: The Promise of Epigenetic and Epitranscriptomic Modulation

Related Experiment Video

Updated: May 31, 2026

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

Lilia Abbad1, Christos Chatziantoniou

  • 1Faculty of Medicine, INSERM UMR S 1155, Common and Rare Kidney Diseases, Tenon Hospital, Sorbonne University, Paris, France.

Journal of the American Society of Nephrology : JASN
|May 29, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
AKICKDfibrosisglomerular diseasespathophysiologyprogression of kidney diseaserenal hemodynamicssignalingtarget organ damagetransgenic mouse

Related Experiment Videos

Last Updated: May 31, 2026

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...

Articles linked to this work by shared authors, journal, and citation graph.

Advances and challenges in kidney fibrosis therapeutics.

Nature reviews. Nephrology·2025

Role of Periostin and Nuclear Factor-κB Interplay in the Development of Diabetic Nephropathy.

Cells·2022

Interorgan Signaling in Kidney Health and Disease.

Journal of the American Society of Nephrology : JASN·2026

Association of Medicare's ESRD Treatment Choices Model with Timely Access to Kidney Transplantation in the Southeastern United States.

Journal of the American Society of Nephrology : JASN·2026

Proteinuria, eGFR Decline, and the Pathway to Kidney Failure in Alport Syndrome.

Journal of the American Society of Nephrology : JASN·2026

The Dosage Logic of PKD1: RNA Regulation and Therapeutic Derepression.

Journal of the American Society of Nephrology : JASN·2026

Risk of Venous Thromboembolism in Kidney Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026

Empagliflozin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Randomized Controlled Trial.

Journal of the American Society of Nephrology : JASN·2026

G-quadruplex ligand-mediated CHK1 and ERα suppression in endocrine-sensitive and endocrine-resistant luminal breast cancer cells.

Cell cycle (Georgetown, Tex.)·2026

Obeticholic acid: discovery, clinical translation, and regulatory withdrawal.

European review for medical and pharmacological sciences·2026

An Act of DeFianCe: Targeting DKK1 in Metastatic Colorectal Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

An Orthotopic Xenograft Model for Preclinical Evaluation of CAR T Cell Therapy in Glioblastoma.

Current protocols·2026

Cardiac toxicity and dysrhythmias in acute poisoning: a ten-year cohort study.

Clinical toxicology (Philadelphia, Pa.)·2026

Anticancer activity and ADME-toxicity evaluation of novel synthesized chalcone-sulfonate derivatives in osteosarcoma cells and the effect of electroporation.

Future medicinal chemistry·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us